Literature DB >> 3097786

Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature.

J I Sussman, E J Baron, S M Goldberg, M H Kaplan, R A Pizzarello.   

Abstract

A case of Lactobacillus casei endocarditis that occurred on a Carpentier-Edwards porcine valve is reported. A review of the literature, which yielded 23 other reports of endocarditis due to this organism, suggests that Lactobacillus is a rare cause of endocarditis. Typically, it occurs in a patient with preexisting structural heart disease (20 of 24 [83%]) and often with some form of recent dental infection or manipulation (18 of 24 [75%]). Six (25%) of 24 patients died of this infection; however, only one (5%) of 19 who were treated with adequate antimicrobial therapy died. The response to antimicrobial therapy was better in the more recent cases. Of those 18 patients who completed a full course of therapy, seven (39%) experienced a relapse; five of these were cured of their infection with a second course of antimicrobial therapy, which usually included higher doses of intravenous penicillin. Our case represents the second reported case that required surgical intervention for cure. Embolic phenomena occurred in 10 (42%) of 24 cases. Various combinations of antibiotics have been successful in achieving cure; however, at present, high-dose penicillin (greater than 25 million units/day) in combination with an aminoglycoside for a period of six weeks appears to be the optimum therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097786     DOI: 10.1093/clinids/8.5.771

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  27 in total

1.  Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host.

Authors:  S J Antony
Journal:  J Natl Med Assoc       Date:  2000-02       Impact factor: 1.798

Review 2.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

3.  Fatal case of endocarditis due to Weissella confusa.

Authors:  James D Flaherty; Paul N Levett; Floyd E Dewhirst; Theodore E Troe; John R Warren; Stuart Johnson
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin.

Authors:  M Chomarat; D Espinouse
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

5.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

Review 6.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Endocarditis caused by Lactobacillus.

Authors:  A Vaghjimal; L I Lutwick; E K Chapnick
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

Review 8.  Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

Authors:  J P Cannon; T A Lee; J T Bolanos; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

9.  Endocarditis of the native aortic valve caused by Lactobacillus jensenii.

Authors:  Soumya Patnaik; Carlos Daniel Davila; Anupama Chennupati; Alexander Rubin
Journal:  BMJ Case Rep       Date:  2015-03-06

10.  In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.

Authors:  L de la Maza; K L Ruoff; M J Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.